BSN 315 HESI EXAM
PHARMACOLOGY V1
(SETS 1, 2 & 3)
2026/2027
150 QUESTIONS | VERIFIED QUESTIONS AND ANSWERS
NIGHTINGALE COLLEGE | 100% CORRECT ANSWERS | GRADED A+
Core Domains:
Pharmacokinetics & Pharmacodynamics | Cardiovascular Medications
Respiratory & Gastrointestinal Agents | Endocrine & Metabolic Medications
Anti-Infective Therapies | Pain Management & Analgesics
CNS & Psychiatric Medications | Drug Interactions & Adverse Effects
Pediatric & Geriatric Pharmacology
Scenario-Based Clinical Decision-Making
Nightingale College – BSN 315 Pharmacology – Aligned Format
, BSN 315 HESI Pharmacology V1 Exam
Introduction
This BSN 315 HESI Pharmacology V1 Exam for 2026/2027 reflects a standardized assessment used to
evaluate competency in pharmacology for nursing practice. The exam measures understanding of
drug mechanisms, therapeutic uses, adverse effects, interactions, and scenario-based clinical decision-
making essential for safe medication management.
Exam Structure
The BSN 315 HESI Pharmacology V1 Exam consists of 150 multiple-choice questions organized into 3
sets of 50 questions each. The exam covers safe medication administration, clinical reasoning, and
patient-centered care. Questions include single-best-answer and scenario-based pharmacology items
designed to evaluate comprehensive understanding of pharmacological principles.
Instructions
Read each question carefully before selecting your answer. All questions are presented in bold.
Correct answers are indicated in bold and green. Rationales explaining pharmacologic principles,
clinical reasoning, and patient safety considerations are provided in italic font.
SET 1 (Questions 1-50)
Pharmacokinetics & Pharmacodynamics
1. Which process describes how a medication moves from the site of administration into
the bloodstream?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Rationale: Absorption is the movement of a drug from its site of administration into the
bloodstream. Factors affecting absorption include route of administration, blood flow, surface
area, and drug formulation. IV administration has 100% bioavailability as it bypasses
absorption.
2. What is the meaning of 'first-pass effect' in pharmacology?
A. The first dose of medication given to a patient
B. Metabolism of a drug by the liver before it reaches systemic circulation
C. The initial therapeutic effect
D. Drug elimination by the kidneys
Rationale: The first-pass effect occurs when drugs absorbed from the GI tract pass through the
liver via the portal circulation before reaching systemic circulation. This can significantly
reduce the amount of active drug available. Drugs with high first-pass metabolism may
require higher oral doses or alternative routes.
3. Which laboratory test is most important to monitor for a patient on long-term
aminoglycoside therapy?
A. Liver function tests
B. Serum creatinine and BUN
C. Complete blood count
Page 2 of 35
, BSN 315 HESI Pharmacology V1 Exam
D. Coagulation studies
Rationale: Aminoglycosides (gentamicin, tobramycin) are nephrotoxic and can cause acute
kidney injury. Monitoring serum creatinine and BUN is essential to detect early kidney
damage. Peak and trough levels are also monitored to ensure therapeutic levels while avoiding
toxicity.
4. What is the half-life of a medication?
A. Time for the drug to reach peak concentration
B. Time required for plasma concentration to decrease by 50%
C. Time for complete elimination
D. Time for drug absorption
Rationale: Half-life (t½) is the time required for the plasma concentration of a drug to
decrease by 50%. It determines dosing intervals. After approximately 4-5 half-lives, a drug
reaches steady state or is essentially eliminated. Drugs with short half-lives require more
frequent dosing.
5. A drug that binds to a receptor and produces a therapeutic effect is called:
A. Antagonist
B. Agonist
C. Inhibitor
D. Blocker
Rationale: An agonist is a drug that binds to a receptor and activates it, producing a
therapeutic effect. A full agonist produces maximum response, while a partial agonist produces
a submaximal response. Antagonists bind to receptors but block the action of agonists.
6. Which route of medication administration has the fastest onset of action?
A. Oral
B. Intramuscular
C. Intravenous
D. Subcutaneous
Rationale: Intravenous administration provides immediate drug delivery into the bloodstream
with 100% bioavailability and fastest onset of action. Other routes require absorption which
delays onset. IV is preferred for emergency situations and when rapid effect is needed.
7. What is the therapeutic index of a drug?
A. Ratio of toxic dose to therapeutic dose
B. Time to reach steady state
C. Amount of drug absorbed
D. Rate of drug elimination
Rationale: The therapeutic index (TI) is the ratio of the toxic dose to the therapeutic dose
(TD50/ED50). A high TI indicates a wide margin of safety, while a low TI indicates a narrow
therapeutic window requiring careful monitoring. Drugs like digoxin and warfarin have
narrow therapeutic indices.
8. Which factor most significantly affects drug distribution?
A. Drug color
B. Protein binding and tissue permeability
C. Drug packaging
D. Tablet size
Page 3 of 35
, BSN 315 HESI Pharmacology V1 Exam
Rationale: Drug distribution is affected by protein binding (only unbound drug is active),
tissue permeability, blood flow, and body composition. Highly protein-bound drugs can be
displaced by other drugs, causing increased free drug levels and potential toxicity. Lipid
solubility affects blood-brain barrier penetration.
9. Cytochrome P450 enzymes are primarily located in which organ?
A. Kidneys
B. Liver
C. Lungs
D. Heart
Rationale: Cytochrome P450 enzymes are primarily located in the liver and are responsible for
the metabolism of most drugs. Genetic variations, drug interactions, and liver disease can
affect enzyme activity. CYP450 inhibitors increase drug levels, while inducers decrease drug
levels.
10. What is steady state in pharmacokinetics?
A. When the drug is completely eliminated
B. When drug input equals drug elimination
C. When absorption is complete
D. When distribution is finished
Rationale: Steady state is reached when the rate of drug administration equals the rate of
elimination, resulting in stable plasma concentrations. It typically takes 4-5 half-lives to
achieve steady state. Loading doses can achieve therapeutic levels quickly before steady state is
reached.
Cardiovascular Medications
11. A patient taking digoxin develops nausea, vomiting, and visual disturbances. What
should the nurse suspect?
A. Expected side effects
B. Digoxin toxicity
C. Allergic reaction
D. Drug tolerance
Rationale: Nausea, vomiting, and visual disturbances (yellow-green halos) are classic signs of
digoxin toxicity. Other signs include bradycardia and cardiac arrhythmias. The nurse should
hold the medication and obtain a serum digoxin level. Therapeutic range is 0.5-2.0 ng/mL.
12. Which medication requires checking apical heart rate for one full minute before
administration?
A. Lisinopril
B. Digoxin
C. Furosemide
D. Metoprolol
Rationale: Digoxin should be held if the apical heart rate is below 60 bpm in adults. The
medication slows the heart rate by increasing parasympathetic activity and decreasing
conduction through the AV node. Bradycardia increases the risk of digoxin toxicity.
13. A patient on warfarin has an INR of 5.0. What is the priority nursing intervention?
A. Continue current dose
B. Hold the warfarin and notify the provider
C. Increase the dose
Page 4 of 35
PHARMACOLOGY V1
(SETS 1, 2 & 3)
2026/2027
150 QUESTIONS | VERIFIED QUESTIONS AND ANSWERS
NIGHTINGALE COLLEGE | 100% CORRECT ANSWERS | GRADED A+
Core Domains:
Pharmacokinetics & Pharmacodynamics | Cardiovascular Medications
Respiratory & Gastrointestinal Agents | Endocrine & Metabolic Medications
Anti-Infective Therapies | Pain Management & Analgesics
CNS & Psychiatric Medications | Drug Interactions & Adverse Effects
Pediatric & Geriatric Pharmacology
Scenario-Based Clinical Decision-Making
Nightingale College – BSN 315 Pharmacology – Aligned Format
, BSN 315 HESI Pharmacology V1 Exam
Introduction
This BSN 315 HESI Pharmacology V1 Exam for 2026/2027 reflects a standardized assessment used to
evaluate competency in pharmacology for nursing practice. The exam measures understanding of
drug mechanisms, therapeutic uses, adverse effects, interactions, and scenario-based clinical decision-
making essential for safe medication management.
Exam Structure
The BSN 315 HESI Pharmacology V1 Exam consists of 150 multiple-choice questions organized into 3
sets of 50 questions each. The exam covers safe medication administration, clinical reasoning, and
patient-centered care. Questions include single-best-answer and scenario-based pharmacology items
designed to evaluate comprehensive understanding of pharmacological principles.
Instructions
Read each question carefully before selecting your answer. All questions are presented in bold.
Correct answers are indicated in bold and green. Rationales explaining pharmacologic principles,
clinical reasoning, and patient safety considerations are provided in italic font.
SET 1 (Questions 1-50)
Pharmacokinetics & Pharmacodynamics
1. Which process describes how a medication moves from the site of administration into
the bloodstream?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Rationale: Absorption is the movement of a drug from its site of administration into the
bloodstream. Factors affecting absorption include route of administration, blood flow, surface
area, and drug formulation. IV administration has 100% bioavailability as it bypasses
absorption.
2. What is the meaning of 'first-pass effect' in pharmacology?
A. The first dose of medication given to a patient
B. Metabolism of a drug by the liver before it reaches systemic circulation
C. The initial therapeutic effect
D. Drug elimination by the kidneys
Rationale: The first-pass effect occurs when drugs absorbed from the GI tract pass through the
liver via the portal circulation before reaching systemic circulation. This can significantly
reduce the amount of active drug available. Drugs with high first-pass metabolism may
require higher oral doses or alternative routes.
3. Which laboratory test is most important to monitor for a patient on long-term
aminoglycoside therapy?
A. Liver function tests
B. Serum creatinine and BUN
C. Complete blood count
Page 2 of 35
, BSN 315 HESI Pharmacology V1 Exam
D. Coagulation studies
Rationale: Aminoglycosides (gentamicin, tobramycin) are nephrotoxic and can cause acute
kidney injury. Monitoring serum creatinine and BUN is essential to detect early kidney
damage. Peak and trough levels are also monitored to ensure therapeutic levels while avoiding
toxicity.
4. What is the half-life of a medication?
A. Time for the drug to reach peak concentration
B. Time required for plasma concentration to decrease by 50%
C. Time for complete elimination
D. Time for drug absorption
Rationale: Half-life (t½) is the time required for the plasma concentration of a drug to
decrease by 50%. It determines dosing intervals. After approximately 4-5 half-lives, a drug
reaches steady state or is essentially eliminated. Drugs with short half-lives require more
frequent dosing.
5. A drug that binds to a receptor and produces a therapeutic effect is called:
A. Antagonist
B. Agonist
C. Inhibitor
D. Blocker
Rationale: An agonist is a drug that binds to a receptor and activates it, producing a
therapeutic effect. A full agonist produces maximum response, while a partial agonist produces
a submaximal response. Antagonists bind to receptors but block the action of agonists.
6. Which route of medication administration has the fastest onset of action?
A. Oral
B. Intramuscular
C. Intravenous
D. Subcutaneous
Rationale: Intravenous administration provides immediate drug delivery into the bloodstream
with 100% bioavailability and fastest onset of action. Other routes require absorption which
delays onset. IV is preferred for emergency situations and when rapid effect is needed.
7. What is the therapeutic index of a drug?
A. Ratio of toxic dose to therapeutic dose
B. Time to reach steady state
C. Amount of drug absorbed
D. Rate of drug elimination
Rationale: The therapeutic index (TI) is the ratio of the toxic dose to the therapeutic dose
(TD50/ED50). A high TI indicates a wide margin of safety, while a low TI indicates a narrow
therapeutic window requiring careful monitoring. Drugs like digoxin and warfarin have
narrow therapeutic indices.
8. Which factor most significantly affects drug distribution?
A. Drug color
B. Protein binding and tissue permeability
C. Drug packaging
D. Tablet size
Page 3 of 35
, BSN 315 HESI Pharmacology V1 Exam
Rationale: Drug distribution is affected by protein binding (only unbound drug is active),
tissue permeability, blood flow, and body composition. Highly protein-bound drugs can be
displaced by other drugs, causing increased free drug levels and potential toxicity. Lipid
solubility affects blood-brain barrier penetration.
9. Cytochrome P450 enzymes are primarily located in which organ?
A. Kidneys
B. Liver
C. Lungs
D. Heart
Rationale: Cytochrome P450 enzymes are primarily located in the liver and are responsible for
the metabolism of most drugs. Genetic variations, drug interactions, and liver disease can
affect enzyme activity. CYP450 inhibitors increase drug levels, while inducers decrease drug
levels.
10. What is steady state in pharmacokinetics?
A. When the drug is completely eliminated
B. When drug input equals drug elimination
C. When absorption is complete
D. When distribution is finished
Rationale: Steady state is reached when the rate of drug administration equals the rate of
elimination, resulting in stable plasma concentrations. It typically takes 4-5 half-lives to
achieve steady state. Loading doses can achieve therapeutic levels quickly before steady state is
reached.
Cardiovascular Medications
11. A patient taking digoxin develops nausea, vomiting, and visual disturbances. What
should the nurse suspect?
A. Expected side effects
B. Digoxin toxicity
C. Allergic reaction
D. Drug tolerance
Rationale: Nausea, vomiting, and visual disturbances (yellow-green halos) are classic signs of
digoxin toxicity. Other signs include bradycardia and cardiac arrhythmias. The nurse should
hold the medication and obtain a serum digoxin level. Therapeutic range is 0.5-2.0 ng/mL.
12. Which medication requires checking apical heart rate for one full minute before
administration?
A. Lisinopril
B. Digoxin
C. Furosemide
D. Metoprolol
Rationale: Digoxin should be held if the apical heart rate is below 60 bpm in adults. The
medication slows the heart rate by increasing parasympathetic activity and decreasing
conduction through the AV node. Bradycardia increases the risk of digoxin toxicity.
13. A patient on warfarin has an INR of 5.0. What is the priority nursing intervention?
A. Continue current dose
B. Hold the warfarin and notify the provider
C. Increase the dose
Page 4 of 35
